Skip to main content

Table 2 Procedural related complications during and after PDT differentiated by treatment group

From: Percutaneous dilatational tracheotomy in high-risk ICU patients

Complication (I) Heparin (prophylactic dosage)
(n = 101)
(II) Heparin (therapeutic dosage)
(n = 131)
(III) Aspirin and/or P2Y12 receptor inhibitor with heparin (prophylactic or therapeutic dosage) except for triple therapy (n = 290) (IV) DAPT with heparin (therapeutic dosage) (triple therapy)
(n = 149)
Overall
(n = 671)
P-value
Intraprocedural bleeding n (%) 5 (5) 4 (3) 13 (4) 4 (3) 26 (4) ns
Postprocedural bleeding n (%) 9 (9) 9 (7) 19 (7) 11 (7) 48 (7) ns
Intra-/postproceddural bleeding n (%) 14 (14) 13 (10) 32 (11) 15 (10) 74 (11) ns
Intra-/postproceddural pneumothorax n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) ns
Intraprocedural accidental cannula dislocation n (%) 3 (3) 7 (5) 2 (1) 1 (1) 13 (2) ns
Intraprocedural accidental tubus dislocation n (%) 0 (0) 2 (2) 4 (1) 2 (1) 8 (1) ns
Postprocedural tracheocutaneous fistula n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) ns
Postprocedural infection n (%) 1 (1) 0 (0) 4 (1) 0 (0) 5 (1) ns
Postprocedural granulation at the tracheostoma n (%) 1 (1) 2 (2) 0 (0) 1 (1) 4 (1) ns
Postprocedural wound healing n (%) 1 (1) 0 (0) 1 (1) 0 (0) 2 (0) ns
Intraprocedural O2 desaturation n (%) 2 (2) 1 (1) 7 (2) 0 (0) 10 (1) ns
Intraprocedural hypotension n (%) 5 (5) 3 (2) 17 (6) 5 (3) 30 (4) ns
Intraprocedural cardiac arrhythmia n (%) 1 (1) 0 (0) 0 (0) 0 (0) 1 (0) ns
Intraprocedural fracture of tracheal cartilage n (%) 1 (1) 9 (7) 13 (4) 6 (4) 29 (4) ns
Intraprocedural resuscitation n (%) 1 (1) 0 (0) 4 (1) 0 (0) 5 (1) ns
Intra/postprocedural death n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) ns
  1. p-values < 0.05 were considered as significant; ns non-significant